1L-N¹-benzyloxycarbonyl-O⁶-(2-benzyloxycarbonylamino-α-D-ribo-2,3-dideoxy-hexopyranosyl)-O⁵-[O²,O³-bis-(4-nitro-benzoyl)-O⁵-(toluene-4-sulfonyl)-β-D-xylofuranosyl]-N³,O⁴-carbonyl-2-deoxy-streptamine | 68537-55-3

• 分子结构分类: 有机化合物
• 英文名称: 1L-N¹-benzyloxycarbonyl-O⁶-(2-benzyloxycarbonylamino-α-D-ribo-2,3-dideoxy-hexopyranosyl)-O⁵-[O²,O³-bis-(4-nitro-benzoyl)-O⁵-(toluene-4-sulfonyl)-β-D-xylofuranosyl]-N³,O⁴-carbonyl-2-deoxy-streptamine
• CAS: 68537-55-3
• 化学式: C₅₅H₅₅N₅O₂₃S
• 分子量: 1186.13
• InChiKey: WTVSYKGQIAUBLS-IUIPCXHLSA-N

反应信息

• 作为反应物：
  描述：

  1L-N¹-benzyloxycarbonyl-O⁶-(2-benzyloxycarbonylamino-α-D-ribo-2,3-dideoxy-hexopyranosyl)-O⁵-[O²,O³-bis-(4-nitro-benzoyl)-O⁵-(toluene-4-sulfonyl)-β-D-xylofuranosyl]-N³,O⁴-carbonyl-2-deoxy-streptamine 在 吡啶 、 叠氮化锂 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 1D-O⁴-(6-azido-2-benzyloxycarbonylamino-α-D-ribo-2,3,6-trideoxy-hexopyranosyl)-O⁵-[5-azido-O²,O³-bis-(4-nitro-benzoyl)-β-D-5-deoxy-xylofuranosyl]-N³-benzyloxycarbonyl-N¹,O⁶-carbonyl-2-deoxy-streptamine
  参考文献：
  名称：

  Synthesis of 5"-amino-3',5"-dideoxybutirosin A.

  摘要：

  The titled compound was prepared by condensation of 3'-deoxyparomamine derivative (5) with 2, 3-O-bis(p-nitrobenzoyl)-5-O-tosyl-D-xylofuranosyl bromide followed by 1-N-acylation with the active ester of (S)-4-benzyloxycarbonylamino-2-hydroxybutyric acid.

  DOI：

  10.7164/antibiotics.31.863
• 作为产物：
  描述：

  1L-N¹-benzyloxycarbonyl-O⁶-(2-benzyloxycarbonylamino-O⁴,O⁶-cyclohexane-1,1-diyl-α-D-ribo-2,3-dideoxy-hexopyranosyl)-O⁵-[O²,O³-bis-(4-nitro-benzoyl)-O⁵-(toluene-4-sulfonyl)-β-D-xylofuranosyl]-N³,O⁴-carbonyl-2-deoxy-streptamine 在 溶剂黄146 作用下， 以 1,4-二氧六环 为溶剂， 生成 1L-N¹-benzyloxycarbonyl-O⁶-(2-benzyloxycarbonylamino-α-D-ribo-2,3-dideoxy-hexopyranosyl)-O⁵-[O²,O³-bis-(4-nitro-benzoyl)-O⁵-(toluene-4-sulfonyl)-β-D-xylofuranosyl]-N³,O⁴-carbonyl-2-deoxy-streptamine
  参考文献：
  名称：

  Synthesis of 5"-amino-3',5"-dideoxybutirosin A.

  摘要：

  The titled compound was prepared by condensation of 3'-deoxyparomamine derivative (5) with 2, 3-O-bis(p-nitrobenzoyl)-5-O-tosyl-D-xylofuranosyl bromide followed by 1-N-acylation with the active ester of (S)-4-benzyloxycarbonylamino-2-hydroxybutyric acid.

  DOI：

  10.7164/antibiotics.31.863